Barclays Increases Oscar Health (NYSE:OSCR) Price Target to $13.00

Oscar Health (NYSE:OSCR) had its price target boosted by equities research analysts at Barclays from $11.00 to $13.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has an “underweight” rating on the stock. Barclays‘s target price would suggest a potential downside of 12.55% from the stock’s previous close.

A number of other analysts have also recently issued reports on OSCR. Piper Sandler decreased their target price on Oscar Health from $14.00 to $13.00 and set a “neutral” rating for the company in a report on Thursday, August 14th. Wall Street Zen cut shares of Oscar Health from a “hold” rating to a “sell” rating in a research report on Saturday, August 9th. Baird R W lowered shares of Oscar Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 25th. Wells Fargo & Company raised their target price on shares of Oscar Health from $10.00 to $14.00 and gave the company an “underweight” rating in a research note on Tuesday, October 7th. Finally, Zacks Research upgraded shares of Oscar Health from a “strong sell” rating to a “hold” rating in a report on Monday, October 13th. Six investment analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Reduce” and an average target price of $13.57.

Oscar Health Trading Down 16.1%

Shares of OSCR stock traded down $2.85 on Monday, reaching $14.87. 35,611,350 shares of the stock were exchanged, compared to its average volume of 14,514,667. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67. The stock has a market cap of $3.84 billion, a P/E ratio of -13.25 and a beta of 1.88. The firm has a 50 day moving average of $19.17 and a two-hundred day moving average of $16.85. Oscar Health has a 1-year low of $11.20 and a 1-year high of $23.80.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.02. The firm had revenue of $2.93 billion during the quarter, compared to the consensus estimate of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The firm’s quarterly revenue was up 23.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.22) earnings per share. Oscar Health has set its FY 2025 guidance at EPS. On average, research analysts anticipate that Oscar Health will post 0.69 EPS for the current year.

Insider Activity at Oscar Health

In other news, insider Mario Schlosser sold 395,000 shares of the company’s stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $18.43, for a total value of $7,279,850.00. Following the completion of the transaction, the insider directly owned 501,148 shares in the company, valued at approximately $9,236,157.64. This represents a 44.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 24.39% of the company’s stock.

Institutional Investors Weigh In On Oscar Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in OSCR. OneDigital Investment Advisors LLC boosted its position in Oscar Health by 0.6% in the 3rd quarter. OneDigital Investment Advisors LLC now owns 138,271 shares of the company’s stock valued at $2,617,000 after buying an additional 779 shares during the last quarter. Highbridge Capital Management LLC purchased a new stake in shares of Oscar Health during the third quarter worth about $1,308,000. Raiffeisen Bank International AG acquired a new position in shares of Oscar Health in the third quarter worth about $1,171,000. Maridea Wealth Management LLC purchased a new position in Oscar Health in the third quarter valued at about $331,000. Finally, GSA Capital Partners LLP boosted its holdings in Oscar Health by 238.8% in the third quarter. GSA Capital Partners LLP now owns 35,753 shares of the company’s stock valued at $677,000 after purchasing an additional 25,199 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.